Study on the Effect of Transcranial Magnetic Stimulation in Mild to Moderate Alzheimer's Disease
Prospective, Randomized, Evaluator-blind, Single Center Study on the Effect of Transcranial Magnetic Stimulation in Mild to Moderate Alzheimer's Disease
1 other identifier
interventional
32
1 country
1
Brief Summary
The investigators will compare cognitition, mood (depression), ADL, and brain structural and functional MRI before and after 4-week transcranial magnetic stimulation in patients with mild to moderate Alzheimer's disease. The investigators also compare the change of cognitition, mood (depression), ADL, and brain structural and functional MRI between TMS group and sham coil group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2020
CompletedFirst Posted
Study publicly available on registry
February 7, 2020
CompletedStudy Start
First participant enrolled
February 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 7, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 7, 2022
CompletedFebruary 7, 2020
February 1, 2020
1 year
January 22, 2020
February 5, 2020
Conditions
Outcome Measures
Primary Outcomes (9)
the short term change of K-MMSE score in TMS group
the short term change of K-MMSE (Korean version of mini mental status exam) score in TMS group
4 weeks
the short term change of K-MoCA score in TMS group
the short term change of K-MoCA (Korean version of Montreal cognitive assessment) score in TMS group
4 weeks
the short term change of ADAS-Cog score in TMS group
the short term change of ADAS-Cog(the Alzheimer's disease assessment scale-cognitive subscale) score in TMS group
4 weeks
the short term change of COWAT score in TMS group
the short term change of COWAT(controlled oral word association) score in TMS group
4 weeks
the short term change of Stroop score in TMS group
the short term change of Stroop score in TMS group
4 weeks
the short term change of TMT score in TMS group
the short term change of TMT(trail-making test) score in TMS group
4 weeks
the short term change of RVP score in TMS group
the short term change of RVP(raid visual information processing) score in TMS group
4 weeks
the short term change of SWM score in TMS group
the short term change of SWM (spatial working memory) score in TMS group
4 weeks
the short term change of PRM score in TMS group
the short term change of PRM(pattern recognition memory) score in TMS group
4 weeks
Secondary Outcomes (40)
the long term change of K-MMSE score in TMS group
8 weeks
the long term change of K-MoCA score in TMS group
8 weeks
the long term change of ADAS-Cog score in TMS group
8 weeks
the long term change of COWAT score in TMS group
8 weeks
the long term change of Stroop score in TMS group
8 weeks
- +35 more secondary outcomes
Study Arms (2)
TMS group
ACTIVE COMPARATORTranscranial magnetic stimulation for four weeks
Sham group
SHAM COMPARATORsham coil stimulation for four weeks (Although the sound of sham coil is the same to that of real TMS during intervension, no stimulation is applied. )
Interventions
* stimulation intensity : motor threshold 100% * stimulation frequency : 1600 pulses for 20 minutes * stimulation duration :for four weaks, 20 minutes/day, 5 days per week (Monday - Friday )
no stimulation Although the sound from device during stimulation is similar, no stimulation is applied.
Eligibility Criteria
You may qualify if:
- patients who visited memory clinic of Samsung Medical Center
- aged 55 \~ 90
- diagnosed as probable Alzheimer dementia according to NIA-AA guideline 2011, or MCI patiens with amyloid PET positivity
- below -1SD in SVLTdelayed recall test and RCFT delayed recall test
- K-MMSE \>=18
- no epileptic discharge in EEG
- no history of epilepsy
- no arrhythmia or MI in ECG
- can read and write Korean (literate)
- volunteer and agree to the registration
You may not qualify if:
- no other neurologic deficit which can cause dementia except for Alzheimer's disease
- paitient who has severe cerebral white matter hyperintensities. (deep white matter \>=2.5cm and caps or band \>=1.0 cm)
- patients with severe medical disease including caner and ishemic heart disease
- claustrophobia or allergic to contrast of MRI
- medical deviced which is not removable (e.g pacemaker, cochlear implantation, dental prosthesis)
- history of brain surgery, and intervension or surgery of intra/extracranial artery(e.g. carotid artery stent insertion, CEA)
- patient with dyspnea during resting
- history of loss of consciousness for more than 1 hour except for general anesthesia
- patients who cannot read written material because of poor visual acuity
- patients who cannot communicate because of severe hearing difficulty
- history of ototoxicity medication or exposure severe noises
- determined as inapropriate to participate clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsung Medical Center
Seoul, 135-710, South Korea
Related Publications (11)
Nilakantan AS, Mesulam MM, Weintraub S, Karp EL, VanHaerents S, Voss JL. Network-targeted stimulation engages neurobehavioral hallmarks of age-related memory decline. Neurology. 2019 May 14;92(20):e2349-e2354. doi: 10.1212/WNL.0000000000007502. Epub 2019 Apr 17.
PMID: 30996057BACKGROUNDCotelli M, Manenti R, Cappa SF, Geroldi C, Zanetti O, Rossini PM, Miniussi C. Effect of transcranial magnetic stimulation on action naming in patients with Alzheimer disease. Arch Neurol. 2006 Nov;63(11):1602-4. doi: 10.1001/archneur.63.11.1602.
PMID: 17101829BACKGROUNDCotelli M, Calabria M, Manenti R, Rosini S, Zanetti O, Cappa SF, Miniussi C. Improved language performance in Alzheimer disease following brain stimulation. J Neurol Neurosurg Psychiatry. 2011 Jul;82(7):794-7. doi: 10.1136/jnnp.2009.197848. Epub 2010 Jun 23.
PMID: 20574108BACKGROUNDCotelli M, Manenti R, Cappa SF, Zanetti O, Miniussi C. Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline. Eur J Neurol. 2008 Dec;15(12):1286-92. doi: 10.1111/j.1468-1331.2008.02202.x.
PMID: 19049544BACKGROUNDWang JX, Rogers LM, Gross EZ, Ryals AJ, Dokucu ME, Brandstatt KL, Hermiller MS, Voss JL. Targeted enhancement of cortical-hippocampal brain networks and associative memory. Science. 2014 Aug 29;345(6200):1054-7. doi: 10.1126/science.1252900.
PMID: 25170153BACKGROUNDKoch G, Bonni S, Pellicciari MC, Casula EP, Mancini M, Esposito R, Ponzo V, Picazio S, Di Lorenzo F, Serra L, Motta C, Maiella M, Marra C, Cercignani M, Martorana A, Caltagirone C, Bozzali M. Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease. Neuroimage. 2018 Apr 1;169:302-311. doi: 10.1016/j.neuroimage.2017.12.048. Epub 2017 Dec 19.
PMID: 29277405BACKGROUNDRidding MC, Rothwell JC. Is there a future for therapeutic use of transcranial magnetic stimulation? Nat Rev Neurosci. 2007 Jul;8(7):559-67. doi: 10.1038/nrn2169.
PMID: 17565358BACKGROUNDBondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, Nation DA, Libon DJ, Au R, Galasko D, Salmon DP. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates. J Alzheimers Dis. 2014;42(1):275-89. doi: 10.3233/JAD-140276.
PMID: 24844687BACKGROUNDWeissman MM, Myers JK, Tischler GL, Holzer CE 3rd, Leaf PJ, Orvaschel H, Brody JA. Psychiatric disorders (DSM-III) and cognitive impairment among the elderly in a U.S. urban community. Acta Psychiatr Scand. 1985 Apr;71(4):366-79. doi: 10.1111/j.1600-0447.1985.tb02536.x.
PMID: 4003102BACKGROUNDKim S, Nilakantan AS, Hermiller MS, Palumbo RT, VanHaerents S, Voss JL. Selective and coherent activity increases due to stimulation indicate functional distinctions between episodic memory networks. Sci Adv. 2018 Aug 22;4(8):eaar2768. doi: 10.1126/sciadv.aar2768. eCollection 2018 Aug.
PMID: 30140737RESULTJung YH, Jang H, Park S, Kim HJ, Seo SW, Kim GB, Shon YM, Kim S, Na DL. Effectiveness of Personalized Hippocampal Network-Targeted Stimulation in Alzheimer Disease: A Randomized Clinical Trial. JAMA Netw Open. 2024 May 1;7(5):e249220. doi: 10.1001/jamanetworkopen.2024.9220.
PMID: 38709534DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Duk L Na, MD PhD
Samsung Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 22, 2020
First Posted
February 7, 2020
Study Start
February 7, 2020
Primary Completion
February 7, 2021
Study Completion
February 7, 2022
Last Updated
February 7, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share